- Home
- OPBK vs MXCT Comparison
OPBK vs MXCT Comparison
Compare OPBK & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPBK
- MXCT
- Stock Information
- Founded
- OPBK 2005
- MXCT 1999
- Country
- OPBK United States
- MXCT United States
- Employees
- OPBK N/A
- MXCT N/A
- Industry
- OPBK Major Banks
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OPBK Finance
- MXCT Health Care
- Exchange
- OPBK Nasdaq
- MXCT Nasdaq
- Market Cap
- OPBK 204.6M
- MXCT 242.4M
- IPO Year
- OPBK 2018
- MXCT 2021
- Fundamental
- Price
- OPBK $14.54
- MXCT $1.40
- Analyst Decision
- OPBK Hold
- MXCT Buy
- Analyst Count
- OPBK 1
- MXCT 4
- Target Price
- OPBK $15.50
- MXCT $7.50
- AVG Volume (30 Days)
- OPBK 44.3K
- MXCT 1.2M
- Earning Date
- OPBK 10-23-2025
- MXCT 08-06-2025
- Dividend Yield
- OPBK 3.40%
- MXCT N/A
- EPS Growth
- OPBK 8.15
- MXCT N/A
- EPS
- OPBK 1.48
- MXCT N/A
- Revenue
- OPBK $84,078,000.00
- MXCT $35,754,000.00
- Revenue This Year
- OPBK $22.05
- MXCT N/A
- Revenue Next Year
- OPBK $10.50
- MXCT $14.79
- P/E Ratio
- OPBK $9.54
- MXCT N/A
- Revenue Growth
- OPBK 9.17
- MXCT N/A
- 52 Week Low
- OPBK $10.43
- MXCT $1.26
- 52 Week High
- OPBK $18.57
- MXCT $5.20
- Technical
- Relative Strength Index (RSI)
- OPBK 65.13
- MXCT 31.00
- Support Level
- OPBK $14.10
- MXCT $1.37
- Resistance Level
- OPBK $14.37
- MXCT $1.48
- Average True Range (ATR)
- OPBK 0.37
- MXCT 0.09
- MACD
- OPBK 0.08
- MXCT 0.02
- Stochastic Oscillator
- OPBK 82.23
- MXCT 46.43
About OPBK OP Bancorp
OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.